Information
Radnostix Recalls Gelatin Capsule Pack for use with the Sodium Iodide I-131
This is a Class III recall. This product is unlikely to cause adverse health reactions but violates FDA regulations.
Source: FDA
InfoRecall #D-0401-2026Drug / Pharmaceutical
Radnostix Recalls Gelatin Capsule Pack for use with the Sodium Iodide I-131
Radnostix · Class III — Regulatory
Product Description
Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003-25; 69208-003-35
Reason for Recall
Failed Tablet/Capsule Specifications
FDA Classification
Class III — Regulatory
A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Distribution
Nationwide in the US, including Puerto Rico
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A regulatory compliance recall has been issued for a pharmaceutical product from Radnostix. The FDA classified this as Class III on February 19, 2026 affecting 2,699 blister cartons. Failed Tablet/Capsule Specifications. It was distributed nationwide. While this classification indicates a low probability of adverse health effects, consumers should be aware of the recall and follow any instructions from the manufacturer.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.